ChromaCode is a molecular diagnostics company with a bioinformatics focus and pedigree from Illumina, Google[x], Luminex, and Caltech. We leverage patented mathematical methods and algorithmic enhancements to enrich signal processing from the most popular life science instrumentation. We are using this to extract new information on biochemistry reactions and substantially increase the performance capabilities of today's gold-standard biochemical assays at a very low cost.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/27/17 | $12,000,000 | Series B |
Domain Associates Okapi Venture Capital | undisclosed |
| 12/18/19 | $28,000,000 | Series C |
California Institute of Technology Domain Associates Moore Venture Partners New Enterprise Associates Northpond Ventures  Okapi Venture Capital Windham Venture Partners | undisclosed |
| 05/19/20 | $10,000,000 | Series C Extension |
Adjuvant Capital | undisclosed |
